Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Preusser

Showing results (391-400 of 467) with videos related to

Pageof 47
Sort By:
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|May 27, 2024
7 Tesla magnetic resonance spectroscopic imaging predicting IDH status and glioma gradingCornelius Cadrien, Sukrit Sharma, Philipp Lazen, et al.
Neuro-Oncology|July 9, 2026
The European Association for Neuro-oncology (EANO) Consensus Statement on Radiation NecrosisJohnny Duerinck, Martin Van Den Bent, Petter Brandal, et al.
Neuro-Oncology|January 12, 2023
EANO guideline on rational molecular testing of gliomas, glioneuronal, and neuronal tumors in adults for targeted therapy selectionDavid Capper, Guido Reifenberger, Pim J French, et al.
Cancers|October 11, 2018
Audencel Immunotherapy Based on Dendritic Cells Has No Effect on Overall and Progression-Free Survival in Newly Diagnosed Glioblastoma: A Phase II Randomized TrialJohanna Buchroithner, Friedrich Erhart, Josef Pichler, et al.
Infectious Agents and Cancer|February 14, 2023
Prophylactic treatment with oral azithromycin in cancer patients during the COVID-19 pandemic (OnCoVID): a randomized, single-blinded, placebo-controlled phase 2 trialMaximilian J Mair, Agnieszka Maj-Hes, Alina Nussbaumer-Pröll, et al.
Acta Neuropathologica|January 3, 2025
Detection of H3F3A K27M or BRAF V600E in liquid biopsies of brain tumor patients as diagnostic and monitoring biomarker: impact of tumor localization and sampling methodSibylle Madlener, Natalia Stepien, Daniel Senfter, et al.
The Lancet. Oncology|October 30, 2025
Patritumab deruxtecan (HER3-DXd) in patients with active brain metastases of non-small-cell lung cancer (TUXEDO-3): a multicentre, single-arm, phase 2 trialThorsten Fuereder, Javier Garde-Noguera, Juan José García-Mosquera, et al.
Journal for Immunotherapy of Cancer|December 14, 2023
Early kinetics of C reactive protein for cancer-agnostic prediction of therapy response and mortality in patients treated with immune checkpoint inhibitors: a multicenter cohort studyDominik A Barth, Florian Moik, Sarah Steinlechner, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 6, 2025
Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standard for PET imaging of brain metastases: version 1.0Antoine Verger, Nelleke Tolboom, Francesco Cicone, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 15, 2019
PET/MRI versus PET/CT in oncology: a prospective single-center study of 330 examinations focusing on implications for patient management and cost considerationsMarius E Mayerhoefer, Helmut Prosch, Lucian Beer, et al.
Pageof 47

Showing results (391-400 of 467) with videos related to

Sort By:
Pageof 47
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|May 27, 2024
7 Tesla magnetic resonance spectroscopic imaging predicting IDH status and glioma gradingCornelius Cadrien, Sukrit Sharma, Philipp Lazen, et al.
Neuro-Oncology|July 9, 2026
The European Association for Neuro-oncology (EANO) Consensus Statement on Radiation NecrosisJohnny Duerinck, Martin Van Den Bent, Petter Brandal, et al.
Neuro-Oncology|January 12, 2023
EANO guideline on rational molecular testing of gliomas, glioneuronal, and neuronal tumors in adults for targeted therapy selectionDavid Capper, Guido Reifenberger, Pim J French, et al.
Cancers|October 11, 2018
Audencel Immunotherapy Based on Dendritic Cells Has No Effect on Overall and Progression-Free Survival in Newly Diagnosed Glioblastoma: A Phase II Randomized TrialJohanna Buchroithner, Friedrich Erhart, Josef Pichler, et al.
Infectious Agents and Cancer|February 14, 2023
Prophylactic treatment with oral azithromycin in cancer patients during the COVID-19 pandemic (OnCoVID): a randomized, single-blinded, placebo-controlled phase 2 trialMaximilian J Mair, Agnieszka Maj-Hes, Alina Nussbaumer-Pröll, et al.
Acta Neuropathologica|January 3, 2025
Detection of H3F3A K27M or BRAF V600E in liquid biopsies of brain tumor patients as diagnostic and monitoring biomarker: impact of tumor localization and sampling methodSibylle Madlener, Natalia Stepien, Daniel Senfter, et al.
The Lancet. Oncology|October 30, 2025
Patritumab deruxtecan (HER3-DXd) in patients with active brain metastases of non-small-cell lung cancer (TUXEDO-3): a multicentre, single-arm, phase 2 trialThorsten Fuereder, Javier Garde-Noguera, Juan José García-Mosquera, et al.
Journal for Immunotherapy of Cancer|December 14, 2023
Early kinetics of C reactive protein for cancer-agnostic prediction of therapy response and mortality in patients treated with immune checkpoint inhibitors: a multicenter cohort studyDominik A Barth, Florian Moik, Sarah Steinlechner, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 6, 2025
Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standard for PET imaging of brain metastases: version 1.0Antoine Verger, Nelleke Tolboom, Francesco Cicone, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 15, 2019
PET/MRI versus PET/CT in oncology: a prospective single-center study of 330 examinations focusing on implications for patient management and cost considerationsMarius E Mayerhoefer, Helmut Prosch, Lucian Beer, et al.
Pageof 47